Related Experiment Video
Updated: Jul 11, 2026

A Murine Model of Subarachnoid Hemorrhage
Published on: November 21, 2013
Expression of matrix metalloproteinase-9 in thrombin-induced brain edema formation in rats
Kenya Kawakita1, Nobuyuki Kawai, Yasuhiro Kuroda
1Department of Neurological Surgery, Kagawa University School of Medicine, Kagawa, Japan.
Abstract:
Recent evidence has demonstrated that thrombin plays an important role in the development of brain edema by the blood-brain barrier disruption in intracerebral hemorrhage. Matrix metalloproteinases (MMPs), a family of proteolytic enzymes that degrade the extracellular matrix, are implicated in blood-brain barrier disruption. In this study, we examined whether thrombin injection into the brain parenchyma induces the MMP-9 expression in rats. Anesthetized adult rats received an injection of 10 U of thrombin into the basal ganglia. At 12, 24, and 72 hours after the thrombin injection, brain water content and the expression of MMP-9 messenger RNA (mRNA) and protein were determined. The effect of a specific thrombin inhibitor (hirudin) on MMP-9 expression and brain edema formation and general administration of synthetic MMPs inhibitor (GM6001) on brain edema formation were also examined for linking the injury and up-regulation of MMP-9. The brain water contents in the basal ganglia and overlying cortex were rapidly increased at 12 hours, maximized at 24 hours, and slightly decreased at 72 hours. The gelatinase activity of MMP-9 determined with gelatin zymography was detected in the basal ganglia and cortex at 12 hours, maximally expressed at 24 hours, and remained strong 72 hours after thrombin injection. The expression of MMP-9 mRNA in the cortex determined with reverse transcription-polymerase chain reaction was clearly seen at 12 and 24 hours, and became weak 72 hours after thrombin injection. Co-injection of thrombin and hirudin almost completely inhibited the brain edema formation and expressions of MMP-9 mRNA and protein. Administration of broad-spectrum metalloproteinase inhibitor GM6001 significantly reduced the brain edema formation in this model. These results indicate that intraparenchymal thrombin induces brain edema formation through MMP-9 expression in rats. Inhibition of MMPs activity may provide an approach to potentially reduce ongoing edema after intracerebral hemorrhage.
Insights
Thrombin injection in rats causes brain edema by increasing matrix metalloproteinase-9 (MMP-9) expression. Inhibiting thrombin or MMP-9 reduces this edema, suggesting potential treatments for intracerebral hemorrhage.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Thrombin contributes to brain edema after intracerebral hemorrhage by disrupting the blood-brain barrier.
- Matrix metalloproteinases (MMPs), particularly MMP-9, are implicated in blood-brain barrier disruption.
Purpose of the Study:
- To investigate if thrombin injection into the brain parenchyma induces MMP-9 expression in rats.
- To explore the role of MMP-9 in thrombin-induced brain edema.
Main Methods:
- Rats received intraparenchymal thrombin injections.
- Brain water content, MMP-9 mRNA, and protein expression were measured at various time points.
- The effects of thrombin inhibitor (hirudin) and MMP inhibitor (GM6001) were assessed.
Main Results:
- Thrombin injection significantly increased brain water content and MMP-9 expression (mRNA and protein).
- Hirudin co-administration nearly abolished edema and MMP-9 expression.
- GM6001 administration markedly reduced brain edema.
Conclusions:
- Intraparenchymal thrombin induces brain edema formation via MMP-9 up-regulation in rats.
- Inhibiting MMP activity presents a potential therapeutic strategy for reducing edema post-intracerebral hemorrhage.
